Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3607

LikeLikedUnlike

346-360 of 959

Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
MinuteCE®
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
- Sapna Patel, MD
  Peer
- John M. Kirkwood, MD
  Peer
1.00 program credits
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
MinuteCE®
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
- Hussein Tawbi, MD, PhD
  Peer
- Paolo A. Ascierto, MD
  Peer
1.00 program credits
Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
CME/CE
Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
  Peer
- Amy Mottl, MD, MPH
  Peer
- Muthiah Vaduganathan, MD, MPH
  Peer
0.50 credits
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
CME/CE
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
- Reshma L. Mahtani, DO
  Peer
0.25 credits
MinuteCE®
Breaking Barriers in AML: Risk Stratification, Molecular Profiling, and Novel Menin-Directed Treatment Options
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 credits 10 episodes
Community Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management
CME/CE
Community Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management
- Robert J. Motzer, MD
  Peer
- Elizabeth R. Plimack, MD, MS, FASCO
  Peer
0.25 credits
advertisement
Stratifying Risk to Guide Therapy in R/R AML 
MinuteCE®
Stratifying Risk to Guide Therapy in R/R AML 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Molecular Profiling as a Cornerstone of Precision AML Therapy
MinuteCE®
Molecular Profiling as a Cornerstone of Precision AML Therapy
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Menin Inhibitors: Biologic and Clinical Rationale 
MinuteCE®
Menin Inhibitors: Biologic and Clinical Rationale 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 
MinuteCE®
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
MinuteCE®
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Managing Adverse Events Associated With Menin Inhibitors 
MinuteCE®
Managing Adverse Events Associated With Menin Inhibitors 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
advertisement
Applying Evidence to Clinical Practice 
MinuteCE®
Applying Evidence to Clinical Practice 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Emerging Directions in Menin-Directed AML Therapy 
MinuteCE®
Emerging Directions in Menin-Directed AML Therapy 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Ongoing Clinical Trials in AML With Menin Inhibitors 
MinuteCE®
Ongoing Clinical Trials in AML With Menin Inhibitors 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended